Feeling cold while taking GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound)the latter being a dual GIP/GLP-1 receptor agonistis something many patients report anecdotally, though it is not listed as an official adverse effect in FDA-approved labeling for these medications
Target 25 to 35 grams of fiber daily, building up gradually to avoid bloating
It is which compounding pharmacy is filling the prescription, and whether that pharmacy meets the basic transparency and accreditation standards described elsewhere on this page
Additionally, it slows down the emptying of the stomach and reduces appetite, allowing for more effective nutrition absorption
Financial Considerations: Insurance coverage and out-of-pocket costs vary significantly between medications
Stay committed, engage with your healthcare team, and embrace the support available to you